Drug shortage

Minocycline Hydrochloride Capsule · Teva Pharmaceuticals USA, Inc.

FDA drug shortage · To Be Discontinued · updated May 23, 2025

Key facts

Generic name Minocycline Hydrochloride Capsule
Company Teva Pharmaceuticals USA, Inc.
Presentation Minocycline Hydrochloride, Capsule, 75 mg (NDC 0591-3153-01)
Dosage form Capsule
Status To Be Discontinued
Therapeutic category Anti-Infective
Package NDCs 0591-3153-01
First posted May 23, 2025
Last updated May 23, 2025
Discontinued May 23, 2025

At a glance

  • 1–9 Package NDCs affected
  • 1–9 FDA shortage records for this drug

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA drug shortages

The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.

Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date:

Browse all FDA drug shortages